Cafepharma Today

June 20 2025 - Gene therapy faces fresh uncertainty as two more top FDA officials depart
Gene therapy faces fresh uncertainty as two more top FDA officials depart
Eli Lilly (LLY) sees strong demand for Mounjaro in India
A longer ‘winter’: Public funding slowdown heightens pressure on biotech startups
Is DTC pharma advertising coming to an end?
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Gubra's weekly amylin obesity asset well-tolerated, tied to weight loss in phase 1 trial
Fierce Biotech
Wednesday, November 13, 2024 - 9:46pm
tags:
Gubra, obesity, GUBamy, clinical trials
[podcast]FDA's Foreign Inspections of Drug Manufacturers Have Not Rebounded to Pre-Pandemic Levels
GAO,gov
Wednesday, November 13, 2024 - 9:44pm
tags:
GAO, regulatory, foreign drug inspections, FDA
Marinus cuts 45% of staff after key medicine stumbled in pair of phase 3 trials
Fierce Pharma
Wednesday, November 13, 2024 - 7:29pm
tags:
Marinus Pharmaceuticals, layoffs, Ztalmy
BioNTech to buy Biotheus, gaining control of cancer bispecific
BioPharma Dive
Wednesday, November 13, 2024 - 11:30am
tags:
BioNTech, M&A, Biotheus, Summit Therapeutics, cancer bispecifics
Syros flunks phase 3 blood cancer trial, triggering loan default and share-price plunge
Fierce Biotech
Wednesday, November 13, 2024 - 11:29am
tags:
Syros Pharmaceuticals, clinical trials, tamibarotene
After election, FDA's Califf lays out hopes for his Trump-appointed successor
Fierce Pharma
Wednesday, November 13, 2024 - 11:22am
tags:
FDA, Robert Califf, regulatory
Fledgling Obesity Biotech Metsera Raises Another $215M for Long-Acting GLP-1
BioSpace
Wednesday, November 13, 2024 - 11:20am
tags:
Metsera, funding, obesity
Hidden data on obesity prospect wipe $12B off Amgen market cap
Fierce Biotech
Wednesday, November 13, 2024 - 11:10am
tags:
Amgen, MariTide, obesity, clinical trials
FDA hits Kezar's zetomipzomib program with 2nd clinical hold in 2 months
Fierce Biotech
Wednesday, November 13, 2024 - 11:09am
tags:
Kezar Life Sciences, FDA, zetomipzomib, clinical trials, autoimmune hepatitis
Japan's Otsuka Pharma & ICU Medical sign $200 M deal to create joint venture in North America for manufacturing IV solutions
BioSpectrum Asia
Wednesday, November 13, 2024 - 11:08am
tags:
Otsuka, ICU Medical, IVs
London "is number one European city in life sciences"
Pharmaphorum
Wednesday, November 13, 2024 - 10:57am
tags:
London, UK, Europe
Sanofi wins appeal in spat with NICE over Sarclisa
Pharmaphorum
Wednesday, November 13, 2024 - 10:53am
tags:
Sanofi, NHS, NICE, relapsed or refractory multiple myeloma, Sarclisa
Pharma’s grip on cancer R&D is having unintended consequences
Pharma Voice
Wednesday, November 13, 2024 - 10:52am
tags:
R&D, cancer, oncology
TRex Bio raises $84M to compete in crowded immune drug field
BioPharma Dive
Wednesday, November 13, 2024 - 10:51am
tags:
TRex Bio, funding, eczema
Merck, AstraZeneca report positive data for Koselugo in adults
MSN/Seeking Alpha
Tuesday, November 12, 2024 - 8:49pm
tags:
AstraZeneca, Merck, Koselugo, clinical trials, neurofibromatosis
GSK launches gynecological cancer initiative after survey reveals care gaps
Medical Marketing and Media
Tuesday, November 12, 2024 - 8:46pm
tags:
GSK, gynecological cancers, biomarkets
AstraZeneca, Daiichi withdraw lung cancer approval application for Enhertu follow-up and try again
Fierce Biotech
Tuesday, November 12, 2024 - 8:44pm
tags:
AstraZeneca, Daiichi Sankyo, lung cancer, FDA, Dato-DXd, Enhertu
GSK partners with Flagship startup to hunt for Parkinson’s drugs
BioPharma Dive
Tuesday, November 12, 2024 - 8:43pm
tags:
GSK, Vesalius Therapeutics, Parkinson's Disease
J&J Brings Ottava into the Forefront of Surgical Robotics with New IDE Approval
Medical Devices and Diagnostics Industry
Tuesday, November 12, 2024 - 8:41pm
tags:
JNJ, Medtech, robotic surgery, Ottava
Pfizer explores sale of hospital drugs unit
CNBC/Reuters
Tuesday, November 12, 2024 - 11:19am
tags:
Pfizer, M&A, hospital drugs, Starboard Value, Pfizer Hospital

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Stir Bars Can't Be Ignored
In the Pipeline
AI Effects on Drug Patents
In the Pipeline
Mirror Morphine
In the Pipeline
Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.